BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 25301099)

  • 1. No evidence for desmocollin 3 to serve as a prognostic marker in primary radiotherapy of head and neck cancer.
    Riss D; Pammer J; Grasl MC; Kaider A; Schneider S; Erovic BM
    Wien Klin Wochenschr; 2015 Jan; 127(1-2):24-30. PubMed ID: 25301099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-therapeutic fibrinogen levels are of prognostic significance in locally advanced head and neck cancer.
    Selzer E; Grah A; Heiduschka G; Kornek G; Thurnher D
    Wien Klin Wochenschr; 2016 May; 128(9-10):320-8. PubMed ID: 26919854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of VEGF and FLT-1 receptor expression in patients with locally advanced squamous cell carcinoma of the head and neck.
    Seibold ND; Schild SE; Bruchhage KL; Gebhard MP; Noack F; Rades D
    Strahlenther Onkol; 2013 Aug; 189(8):639-46. PubMed ID: 23748230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Volumetric stratification of cT4 stage head and neck cancer.
    Studer G; Glanzmann C
    Strahlenther Onkol; 2013 Oct; 189(10):867-73. PubMed ID: 24002381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of Napsin-A and Desmocollin-3 in classifying poorly differentiating non-small cell lung carcinoma.
    Ezzat Nel-S; Tahoun N
    J Egypt Natl Canc Inst; 2016 Mar; 28(1):13-22. PubMed ID: 26710975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced membranous and ectopic cytoplasmic expression of DSC2 in esophageal squamous cell carcinoma: an independent prognostic factor.
    Fang WK; Gu W; Li EM; Wu ZY; Shen ZY; Shen JH; Wu JY; Pan F; Lv Z; Xu XE; Huang Q; Xu LY
    Hum Pathol; 2010 Oct; 41(10):1456-65. PubMed ID: 20621329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Sonic Hedgehog Pathway Expression on Outcome in HPV Negative Head and Neck Carcinoma Patients after Surgery and Adjuvant Radiotherapy.
    Enzenhofer E; Parzefall T; Haymerle G; Schneider S; Kadletz L; Heiduschka G; Pammer J; Oberndorfer F; Wrba F; Loader B; Grasl MC; Perisanidis C; Erovic BM
    PLoS One; 2016; 11(12):e0167665. PubMed ID: 27918595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensity-modulated radiation therapy versus three-dimensional conformal radiotherapy in head and neck squamous cell carcinoma: long-term and mature outcomes of a prospective randomized trial.
    Gupta T; Sinha S; Ghosh-Laskar S; Budrukkar A; Mummudi N; Swain M; Phurailatpam R; Prabhash K; Agarwal JP
    Radiat Oncol; 2020 Sep; 15(1):218. PubMed ID: 32938468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of the diagnosis and treatment of cancer located in the head and neck and correlation with expression of prognostic markers.
    Bădulescu F; Bădulescu A; Crişan A; Popescu FC
    Rom J Morphol Embryol; 2013; 54(3):487-97. PubMed ID: 24068395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic biomarkers in patients with human immunodeficiency virus-positive disease with head and neck squamous cell carcinoma.
    Zhang H; Kim S; Chen Z; Nannapaneni S; Chen AY; Moore CE; Sica G; Mosunjac M; Nguyen MLT; D'Souza G; Carey TE; Peterson LA; McHugh JB; Graham M; Komarck CM; Wolf GT; Walline HM; Bellile E; Riddell J; Pai SI; Sidransky D; Westra WH; William WN; Lee JJ; El-Naggar AK; Ferris RL; Seethala R; Grandis JR; Chen ZG; Saba NF; Shin DM;
    Head Neck; 2017 Dec; 39(12):2433-2443. PubMed ID: 28945296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the prognostic role of tumor cell podoplanin expression in locally advanced squamous cell carcinoma of the head and neck.
    Huttenlocher S; Seibold ND; Gebhard MP; Noack F; Thorns C; Hasselbacher K; Wollenberg B; Schild SE; Rades D
    Strahlenther Onkol; 2014 Oct; 190(11):1021-7. PubMed ID: 24928249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is planned neck dissection necessary for head and neck cancer after intensity-modulated radiotherapy?
    Yao M; Hoffman HT; Chang K; Funk GF; Smith RB; Tan H; Clamon GH; Dornfeld K; Buatti JM
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):707-13. PubMed ID: 17379453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Locoregional Control and Toxicity in Head and Neck Carcinoma Patients following Helical Tomotherapy-Delivered Intensity-Modulated Radiation Therapy Compared with 3D-CRT Data.
    Santa Cruz O; Tsoutsou P; Castella C; Khanfir K; Anchisi S; Bouayed S; Matzinger O; Ozsahin M
    Oncology; 2018; 95(2):61-68. PubMed ID: 29895020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck.
    Michalides RJ; van Veelen NM; Kristel PM; Hart AA; Loftus BM; Hilgers FJ; Balm AJ
    Arch Otolaryngol Head Neck Surg; 1997 May; 123(5):497-502. PubMed ID: 9158396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgery or Radiotherapy of the Primary Tumor in T1-2 Head and Neck Squamous Cell Carcinoma with Resectable N3 Nodes: A Multicenter GETTEC Study.
    Carsuzaa F; Thariat J; Gorphe P; Righini C; Cosmidis A; Thureau S; Roge M; De Mones E; Servagi-Vernat S; Tonnerre D; Morinière S; Dugas A; Malard O; Pasquier F; Vergez S; Salleron J; Dufour X
    Ann Surg Oncol; 2019 Oct; 26(11):3673-3680. PubMed ID: 31264120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of p16 expression, nodal status, and smoking on oncologic outcomes of patients with head and neck unknown primary squamous cell carcinoma.
    Dixon PR; Au M; Hosni A; Perez-Ordonez B; Weinreb I; Xu W; Song Y; Huang SH; O'Sullivan B; Goldstein DP; de Almeida JR
    Head Neck; 2016 Sep; 38(9):1347-53. PubMed ID: 27002481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of cancer stem cell marker expression in primary head and neck squamous cell carcinoma shows prognostic value for aldehyde dehydrogenase (ALDH1A1).
    Szafarowski T; Sierdziński J; Ludwig N; Głuszko A; Filipowska A; Szczepański MJ
    Eur J Pharmacol; 2020 Jan; 867():172837. PubMed ID: 31811857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of osteopontin in patients treated with primary radiotherapy for head and neck cancer.
    Etiz D; Ataizi FC; Bayman E; Akcay M; Acikalin MF; Colak E; Ciftci E
    Asian Pac J Cancer Prev; 2013; 14(9):5175-8. PubMed ID: 24175796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of FDG PET metabolic tumor volume in human papillomavirus-positive stage III and IV oropharyngeal squamous cell carcinoma.
    Alluri KC; Tahari AK; Wahl RL; Koch W; Chung CH; Subramaniam RM
    AJR Am J Roentgenol; 2014 Oct; 203(4):897-903. PubMed ID: 25247958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Desmocollin-1 significant correlated with the tumorigenesis and prognosis of HNSCC].
    Kou F; Li F; Wang L; Yu D; Chen C; Chen SM; Xiao BK; Tao ZZ
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 May; 30(10):763-766. PubMed ID: 29798048
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.